These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 37162729)

  • 1. Imaging findings of right cardiac amyloidosis: impact on prognosis and clinical course.
    Tana M; Tana C; Palmiero G; Mantini C; Coppola MG; Limongelli G; Schiavone C; Porreca E
    J Ultrasound; 2023 Sep; 26(3):605-614. PubMed ID: 37162729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of echocardiography and 99mTc-HDP scintigraphy in non-invasive diagnosis of cardiac amyloidosis: A case series and literature review.
    Costache II; Buburuz AM; Crisu D; Statescu AM; Ungureanu C; Aursulesei V
    Medicine (Baltimore); 2019 Sep; 98(38):e17256. PubMed ID: 31567998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of right ventricular systolic function in cardiac amyloidosis.
    Bodez D; Ternacle J; Guellich A; Galat A; Lim P; Radu C; Guendouz S; Bergoend E; Couetil JP; Hittinger L; Dubois-Randé JL; Plante-Bordeneuve V; Deux JF; Mohty D; Damy T
    Amyloid; 2016 Sep; 23(3):158-167. PubMed ID: 27348696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Right ventricular function in AL amyloidosis: characteristics and prognostic implication.
    Cappelli F; Porciani MC; Bergesio F; Perlini S; Attanà P; Moggi Pignone A; Salinaro F; Musca F; Padeletti L; Perfetto F
    Eur Heart J Cardiovasc Imaging; 2012 May; 13(5):416-22. PubMed ID: 22180463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac Structural and Functional Consequences of Amyloid Deposition by Cardiac Magnetic Resonance and Echocardiography and Their Prognostic Roles.
    Knight DS; Zumbo G; Barcella W; Steeden JA; Muthurangu V; Martinez-Naharro A; Treibel TA; Abdel-Gadir A; Bulluck H; Kotecha T; Francis R; Rezk T; Quarta CC; Whelan CJ; Lachmann HJ; Wechalekar AD; Gillmore JD; Moon JC; Hawkins PN; Fontana M
    JACC Cardiovasc Imaging; 2019 May; 12(5):823-833. PubMed ID: 29680336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis.
    Syed IS; Glockner JF; Feng D; Araoz PA; Martinez MW; Edwards WD; Gertz MA; Dispenzieri A; Oh JK; Bellavia D; Tajik AJ; Grogan M
    JACC Cardiovasc Imaging; 2010 Feb; 3(2):155-64. PubMed ID: 20159642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of clinical and imaging features of cardiac amyloidosis: a multicenter study].
    Zhang L; Tang H; Chen L; Wu X; Cheng L; Wang Z; Wang Y; Huang H; Li J; Wang J; Feng B; Zhi G
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Mar; 34(3):295-302. PubMed ID: 24670437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Utility of Echocardiographic Atrial and Ventricular Strain Imaging in Patients With Cardiac Amyloidosis.
    Huntjens PR; Zhang KW; Soyama Y; Karmpalioti M; Lenihan DJ; Gorcsan J
    JACC Cardiovasc Imaging; 2021 Aug; 14(8):1508-1519. PubMed ID: 33744146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Right Ventricular Strain Measured by Two-Dimensional Echocardiography in the Diagnosis of Cardiac Amyloidosis.
    Moñivas Palomero V; Durante-Lopez A; Sanabria MT; Cubero JS; González-Mirelis J; Lopez-Ibor JV; Navarro Rico SM; Krsnik I; Dominguez F; Mingo AM; Hernandez-Perez FJ; Cavero G; Santos SM
    J Am Soc Echocardiogr; 2019 Jul; 32(7):845-853.e1. PubMed ID: 31078369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biventricular assessment of light-chain amyloidosis using 3D speckle tracking echocardiography: Differentiation from other forms of myocardial hypertrophy.
    Vitarelli A; Lai S; Petrucci MT; Gaudio C; Capotosto L; Mangieri E; Ricci S; Germanò G; De Sio S; Truscelli G; Vozella F; Pergolini MS; Giordano M
    Int J Cardiol; 2018 Nov; 271():371-377. PubMed ID: 30049493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodality imaging evaluation of Chagas disease: an expert consensus of Brazilian Cardiovascular Imaging Department (DIC) and the European Association of Cardiovascular Imaging (EACVI).
    Nunes MCP; Badano LP; Marin-Neto JA; Edvardsen T; Fernández-Golfín C; Bucciarelli-Ducci C; Popescu BA; Underwood R; Habib G; Zamorano JL; Saraiva RM; Sabino EC; Botoni FA; Barbosa MM; Barros MVL; Falqueto E; Simões MV; Schmidt A; Rochitte CE; Rocha MOC; Ribeiro ALP; Lancellotti P
    Eur Heart J Cardiovasc Imaging; 2018 Apr; 19(4):459-460n. PubMed ID: 29029074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of right ventricular longitudinal strain imaging, tricuspid annular plane systolic excursion, and cardiac biomarkers for early diagnosis of cardiac involvement and risk stratification in primary systematic (AL) amyloidosis: a 5-year cohort study.
    Bellavia D; Pellikka PA; Dispenzieri A; Scott CG; Al-Zahrani GB; Grogan M; Pitrolo F; Oh JK; Miller FA
    Eur Heart J Cardiovasc Imaging; 2012 Aug; 13(8):680-9. PubMed ID: 22307866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Right ventricular involvement evaluated by cardiac magnetic resonance imaging predicts mortality in patients with light chain amyloidosis.
    Wan K; Sun J; Han Y; Luo Y; Liu H; Yang D; Cheng W; Zhang Q; Zeng Z; Chen Y
    Heart Vessels; 2018 Feb; 33(2):170-179. PubMed ID: 28840397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiac magnetic resonance-feature tracking technique can assess cardiac function and prognosis in patients with myocardial amyloidosis].
    Cui J; Li R; Liu X; Zhao Y; Zhang X; Liu Q; Li T
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Apr; 43(4):660-666. PubMed ID: 37202205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Right ventricular dilation in primary amyloidosis: an independent predictor of survival.
    Patel AR; Dubrey SW; Mendes LA; Skinner M; Cupples A; Falk RH; Davidoff R
    Am J Cardiol; 1997 Aug; 80(4):486-92. PubMed ID: 9285663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rare Forms of Cardiac Amyloidosis: Diagnostic Clues and Phenotype in Apo AI and AIV Amyloidosis.
    Ioannou A; Porcari A; Patel RK; Razvi Y; Sinigiani G; Martinez-Naharro A; Venneri L; Moon J; Rauf MU; Lachmann H; Wechelakar A; Hawkins PN; Gillmore JD; Fontana M
    Circ Cardiovasc Imaging; 2023 Jul; 16(7):523-535. PubMed ID: 37431665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tricuspid regurgitation duration correlates with cardiovascular magnetic resonance-derived right ventricular ejection fraction and predict prognosis in patients with pulmonary arterial hypertension.
    Cho IJ; Oh J; Chang HJ; Park J; Kang KW; Kim YJ; Choi BW; Shin S; Shim CY; Hong GR; Ha JW; Chung N
    Eur Heart J Cardiovasc Imaging; 2014 Jan; 15(1):18-23. PubMed ID: 23704751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Value of Right Ventricular Dysfunction in Patients With AL Amyloidosis: Comparison of Different Techniques by Cardiac Magnetic Resonance.
    Wan K; Lin J; Guo X; Song R; Wang J; Xu Y; Li W; Cheng W; Sun J; Zhang Q; Han Y; Chen Y
    J Magn Reson Imaging; 2020 Nov; 52(5):1441-1448. PubMed ID: 32691470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac amyloidosis: updates in diagnosis and management.
    Mohty D; Damy T; Cosnay P; Echahidi N; Casset-Senon D; Virot P; Jaccard A
    Arch Cardiovasc Dis; 2013 Oct; 106(10):528-40. PubMed ID: 24070600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of cardiac amyloidosis with
    Kircher M; Ihne S; Brumberg J; Morbach C; Knop S; Kortüm KM; Störk S; Buck AK; Reiter T; Bauer WR; Lapa C
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1407-1416. PubMed ID: 30798427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.